Bank of New York Mellon Corp lifted its holdings in Align Technology, Inc. (NASDAQ:ALGN – Get Rating) by 4.9% in the 3rd quarter, Holdings Channel reports. The firm owned 943,794 shares of the medical equipment provider’s stock after buying an additional 43,895 shares during the quarter. Bank of New York Mellon Corp’s holdings in Align Technology were worth $195,470,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of ALGN. Vanguard Group Inc. lifted its stake in shares of Align Technology by 12.1% in the 3rd quarter. Vanguard Group Inc. now owns 8,213,345 shares of the medical equipment provider’s stock valued at $1,701,067,000 after purchasing an additional 889,705 shares during the last quarter. Brown Advisory Inc. raised its holdings in Align Technology by 72.0% in the 2nd quarter. Brown Advisory Inc. now owns 918,812 shares of the medical equipment provider’s stock worth $217,455,000 after acquiring an additional 384,494 shares during the period. Bares Capital Management Inc. raised its holdings in Align Technology by 68.0% in the 2nd quarter. Bares Capital Management Inc. now owns 690,233 shares of the medical equipment provider’s stock worth $163,357,000 after acquiring an additional 279,461 shares during the period. Riverbridge Partners LLC raised its holdings in Align Technology by 5,579.6% in the 3rd quarter. Riverbridge Partners LLC now owns 268,984 shares of the medical equipment provider’s stock worth $55,709,000 after acquiring an additional 264,248 shares during the period. Finally, Echo Street Capital Management LLC raised its holdings in Align Technology by 97.2% in the 2nd quarter. Echo Street Capital Management LLC now owns 492,964 shares of the medical equipment provider’s stock worth $116,670,000 after acquiring an additional 242,988 shares during the period. Institutional investors and hedge funds own 84.90% of the company’s stock.
Analyst Upgrades and Downgrades
ALGN has been the topic of several recent analyst reports. The Goldman Sachs Group upgraded shares of Align Technology from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $165.00 to $307.00 in a report on Thursday, February 2nd. Robert W. Baird lifted their target price on shares of Align Technology from $260.00 to $335.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. Piper Sandler lifted their target price on shares of Align Technology from $255.00 to $360.00 and gave the stock an “overweight” rating in a report on Thursday, February 2nd. StockNews.com initiated coverage on shares of Align Technology in a report on Thursday. They set a “hold” rating on the stock. Finally, Evercore ISI boosted their price objective on shares of Align Technology from $230.00 to $375.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $358.78.
Insider Activity
Align Technology Stock Performance
Shares of Align Technology stock opened at $320.87 on Friday. The firm’s 50-day simple moving average is $296.65 and its 200-day simple moving average is $240.53. Align Technology, Inc. has a twelve month low of $172.05 and a twelve month high of $461.79. The firm has a market cap of $24.58 billion, a P/E ratio of 69.60, a price-to-earnings-growth ratio of 3.08 and a beta of 1.60.
Align Technology Profile
Align Technology, Inc engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion.
Further Reading
- Get a free copy of the StockNews.com research report on Align Technology (ALGN)
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Get Rating).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.